Theralizumab

Product Specifications

CAS Number

906068-56-2

Target

Others|||Immunology/Inflammation related

Related Pathways

Others|||Immunology/Inflammation

Purity

0.9946

Bioactivity

Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TBZ1776 unit

Pectinolide A

Ask

View Details

HY-RS19089 1 Set

Colec10 Mouse Pre-designed siRNA Set A

Ask

View Details

E3363-13B-AP 100 µL

EPHA10 (Ephrin Type-A Receptor 10) (AP) discontinued

Ask

View Details

NBP3-30011 100 µg

Rabbit Polyclonal CHTOP Antibody

Ask

View Details

RC215030L3V 200 µL

PLEKHG5 (NM_020631) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details

H8850 96 Tests

Trinucleotide repeat-containing gene 6A protein (TNRC6A) Mouse ELISA Kit

Ask

View Details